FDA, CDC Recommend Pausing Use Of Johnson & Johnson Vaccine Due To ‘Extremely Rare’ Clots

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention called for a pause Tuesday in the use of Johnson & Johnson’s coronavirus vaccine “out of an abundance of caution” due to an “extremely rare” incidence of blood clots.

Six recipients in the U.S. developed a rare disorder involving blood clots about two weeks after vaccination, The New York Times reported. More than 6.8 million doses of the vaccine have been administered in the U.S.

This is a developing story. Please check back for updates.



Source by [author_name]